Narrowband-UVB treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments K. Boswell,1 H. Cameron,1 J.

Slides:



Advertisements
Similar presentations
ACC3200 Chapter 2: Job Order Costing Job Order Costing.
Advertisements

PowerPoint Authors: Susan Coomer Galbreath, Ph.D., CPA Charles W. Caldwell, D.B.A., CMA Jon A. Booker, Ph.D., CPA, CIA Cynthia J. Rooney, Ph.D., CPA Copyright.
Measuring health output and productivity in the UK: an essential element of public accountability UK Centre for the Measurement of Government Activity.
South East England Phototherapy Managed Clinical Network The First Five Years Nichola Mair Project Coordinator.
Number of phototherapy treatments for Psoriasis and Eczema: Audit of data collected at Whipps Cross over a three year period. Jane Watts Senior Nurse Melissa.
US cost-effectiveness of simvastatin in 20,536 people at different levels of vascular disease risk: randomised placebo-controlled trial UK Medical Research.
HEALTH ECONOMICS BASICS
Costs and Economics of Construction
Review of an established UK home phototherapy service 1998–2011: improving access to a cost-effective treatment for chronic skin disease  H. Cameron,
PAD 505Competitive Success/tutorialrank.com
F.M. Lewis, F.M. Tatnall, S.S. Velangi, C. B. Bunker,
Ready, Set, Go- what you need to do to get going
Laura J. Dixon1,2, Sara M. Witcraft1, Nancye K. McCowan2, & Robert T
Samine M. D. Ruff1; Kristiane A
Validity of the EQ-5D in pemphigus vulgaris and foliaceus patients
To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in Hidradenitis Suppurativa Alicia Pavon Blanco,1.
Anatomical Site Differences of Sodium Laurylsulphate Induced Irritation: Randomised controlled trial D Leskur1, J Bukić1, A Petrić1,2, L Zekan1,2, D Rušić1,
Association of CCL2 with systemic inflammation in Schnitzler’s syndrome Karoline Krause, Robert Sabat, Ellen Witte-Händel, Anne Schulze, Viktoria Puhl,
Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the non-inferiority.
Polyomaviruses of the Skin: Integrating Molecular and Clinical Advances in an Emerging Class of Viruses Jessica C. Sheu1*, Jessica Tran1*, Peter L. Rady2,
A.D. Irvine1,2,3 and P. Mina-Osorio4
Sub-Populations of Dermal Skin Fibroblasts Secrete Distinct Extracellular Matrix: Implications for Using Skin Substitutes in the Clinic Ghetti, M., Topouzi,
Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data M.P. Dizon, A.M. Yu, R.K. Singh, J. Wan, M-M.
M. T. Svendsen1,2. ,, M. T. Ernst3. , K. E. Andersen1,2,4, F
R. Mössner. , D. Wilsmann-Theis. , V. Oji. , P. Gkogkolou. , S. Löhr
Cancer is not a risk factor for bullous pemphigoid
Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway Ingrid Snekvik1,2, Tom I L Nilsen1, 3, Pål R Romundstad1,
Lack of Confidence Interval Reporting in Dermatology: A Call to Action
Chuin Ying Ung, Jonathan M. L. White, Ian R
Fumaric acid esters in combination with a 6-week course of narrow-band UVB provides for an accelerated response as compared to fumaric acid esters monotherapy.
Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa J.R. Ingram*,
Impact of Acute Stress on Itch Sensation and Scratching Behavior in Atopic Dermatitis Patients and Healthy Controls H. Mochizuki1, 2, M. J. Lavery2, L.
High plasma 25-hydroxyvitamin D and high risk of non-melanoma skin cancer: a Mendelian randomisation study of individuals Ulrik C. Winsløw, Børge.
Marked differences in the density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma and the.
Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among.
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase 3 trials.
Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study P. Theut Riis, O.B. Pedersen,
Cumulative exposure to biologics and risk of cancer in psoriasis patients: a meta-analysis of Psonet studies from Israel, Italy, Spain, United Kingdom.
C.I.M. Busard, J.Y.C. Nolte, M.C. Pasch, Ph.I. Spuls
Primary paediatric cutaneous mucinoses
Applying the phenotype approach for rosacea to practice and research
Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis Kyriakou, A. Patsatsi,
Methotrexate restores the function of peripheral blood Treg cells in psoriasis vulgaris via CD73/AMPK/mTOR pathway Kexiang Yan1,Wen Xu2,#,Yike Huang1,Zhenghua.
K. A. Su,1,2 L. A. Habel,3 N. S. Achacoso,3 G. D. Friedman,3 M. M
Methotrexate and azathioprine in severe atopic dermatitis: A 5-year follow up study of a randomised controlled trial L.A.A. Gerbens, S.A.S Hamann, M.W.D.
Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: A cross-sectional analysis of the National Inpatient Sample.
T. Tzellos1,2; H. Yang3; F. Mu3; B. Calimlim4; J. Signorovitch3
Use of emollients and topical glucocorticoids among adolescents with eczema: data from the population-based birth cohort BAMSE S. Lundin,1,2 C.F. Wahlgren,3,4.
F.M. Lewis, F.M. Tatnall, S.S. Velangi, C. B. Bunker,
Health literacy – a new piece of the puzzle in psoriasis care?
A. Al-Janabi1, Z. K. Jabbar-Lopez2, C.E.M. Griffiths1, Z.Z.N. Yiu1
C. M. Olsen, L. F. Wilson, A. C. Green, N. Biswas, J. Loyalka, D. C
Surgical re-excision versus observation for histologically dysplastic nevi: a systematic review of associated clinical outcomes K.T. Vuong1, J. Walker2,
An App Supporting Psoriasis Patients Improves Adherence to Topical Treatment: A randomised controlled trial M.T. Svendsen,1,2,3 F. Andersen,1,4 K.H. Andersen,4.
Use of the hCONSORT Criteria as a Reporting Standard for Herbal Interventions for Common Dermatoses – A Systematic Review J. Ornelas, MD, MAS 1, E. Routt,
Atopic dermatitis, educational attainment and psychological functioning: a national cohort study Authors: Jevgenija Smirnova1,2, Laura von Kobyletzki1,3,
Prevalence and determinants of seborrhoeic dermatitis in a middle aged and elderly population: the Rotterdam Study M.G.H. Sanders, MD1, L.M. Pardo, MD,
Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: A pooled analysis of the Phase 3 VOYAGE 1 and VOYAGE.
Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group Melchers RC1, Willemze.
Patient reported outcome measures for facial skin cancer: a systematic review and evaluation of the quality of their measurement properties Tom Dobbs,
Proposal of a new scoring formula for the DLQI in psoriasis
RCT pilot study comparing localised immersion PUVA with localised narrowband ultraviolet B (NBUVB) for treatment of palmar hand eczema D. Brass1, T.
Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary.
The utility of optical coherence tomography for diagnosis of basal cell carcinoma: a quantitative review N. Reddy and B.T. Nguyen Department of Dermatology,
Epidemiology of basal and cutaneous squamous cell carcinoma in the United Kingdom : a cohort study Z C Venables123, T Nijsten4, K F Wong2, P Autier5,
Individuals with filaggrin-related eczema and asthma have increased long-term medication and hospital admission costs P. Soares, 1 K. Fidler, 1 J. Felton,
Medical Physics Update Photophysics Sub Group
The prevalence of psychological co-morbidity in people with vitiligo: a systematic review and meta-analysis O. Osinubi, M.J. Grainge, L. Hong, A. Ahmed,
Tschandl P1,2, Argenziano G3, Razmara M4, Yap J4
Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study  Jeanette.
Presentation transcript:

Narrowband-UVB treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments K. Boswell,1 H. Cameron,1 J. West,1 C. Fleming,1 S. Ibbotson,1 R. Dawe,1,2 J. Foerster1 1University of Dundee, Medical School; and Department of Dermatology and Photobiology Unit, NHS Tayside, Dundee, U.K. 2National Managed Clinical Network for Phototherapy (Photonet), NHS Scotland, Dundee, U.K. British Journal of Dermatology. DOI: 10.1111/bjd.16716

Introduction What’s already known? NB-UVB is considered expensive. However, existing estimates of treatment costs are largely based on assumptions and do not consider treatment- associated savings.

Objective To define actual costs of NB-UVB incurred by the service provider, as well as treatment-associated cost savings.

Methods: Approach to data collection Validity: compile actually incurred cost, not estimates. Use actual fraction of each staff job plan allocated to phototherapy. Robustness: use data spanning 6 years to define extend of fluctuations. Generality: compile data separately for low-, medium-, large treatment sites to account for variability in individual staff performance, centre-size effects, local factors. Accuracy: list all direct and indirect costs. Comprehensiveness: list treatment-associated cost savings incurred through change in topical treatments.

Methods: Staff- and non-staff costs Primary staff (nurse): hours allocated to treatment administration, documentation, data entry, letter dictation, training, CPD. Data derived from salary scales detailed for each of 4 independent sites. Supporting staff: consultant /non-consultant supervision [hours per job plans], admin [hours allocated to staff to typing and appointment booking], photobiology technician. FEC staff costs: for all staff, include pension, N.I. for hours in job plan Equipment: purchasing price for NB-UVB cabinets, depreciation, average lifetime, replacement kit (bulbs). Med physics/ estate: maintenance, lamp calibration, cleaning, property maintenance, energy, and rates per sqm used by NHS.

Methods: Treatment – associated cost savings Previous data [Foerster, PLoS One, 2017]: Specific reduction of psoriasis-related topical prescriptions, but not unrelated prescriptions, in the 12-month interval after-, compared to 12- months before a course of NB-UVB. Itemize the respective costs using drug tariff.

Results: Cost incurred by NHS Tayside for NB-UVB between 2010 - 2015 Total: £253 ± 64 per course including all overheads One course: 29.7 ± 10.5 sessions One session: £8.50

Results: cost for topical psoriasis treatment in NHS Tayside 2010 – 2015 (n = 1749 patients)

Results: cost for topical psoriasis treatment in NHS Tayside 2010 – 2015 (n = 1749 patients)

Discussion Data represent averages across four separate treatment sites spanning 6 years, minimizing spurious fluctuations and local factors. Data include indirect staff cost and do not rely on estimates. Real NB-UVB cost (£257) and savings (£51) are in sharp contrast to figure used by NICE in Health Technology Appraisals (£1882) of comparator treatments. Real cost per session (£8.50) in sharp contrast to Tariff applied by NHS England (£74 for adults).

Limitations: Only NB-UVB but not PUVA / UVA1 analysed.1 Non-provider cost not analyzed (time off work for patients). No modelling of QALY performed. Data valid for UK-based hospital-based context. (Staff – hours tabulated for translation of cost into other economies. 1Data on PUVA cost: Dawe, R: . Phototherapy in the treatment of skin disease in Scotland, MD thesis, University of Glasgow, 2001, pp 85 to 89

Conclusions What does this study add? We present comprehensive direct and indirect actual cost incurred for NB-UVB by a provider serving a population of 420,000 over six years. Significant savings can be achieved due to the reduced need of topical treatment and delay / avoidance of 3d line systemic treatment. Data necessitate a review of cost figures used by NICE and in NHS Tariff.

The Research Team Colin Fleming Robert Dawe Jonathan West Heather Cameron Sally Ibbotson John Foerster Kirsty Boswell

Call for correspondence Why not join the debate on this article through our correspondence section? Rapid responses should not exceed 350 words, four references and one figure Further details can be found here